Nielsen H, Sørensen M, Martínez F. "一种拉罗替尼杂质13的合成方法" [P]. European Patent, EP 3277504 A1, 2015-04-09.
发明人黄志刚,杨光,马晓峰. "Method for the Synthesis of Larotrectinib Impurity 13" [P]. 中国发明专利, 专利号 CN 113734694 B, 授权公告日 2025-02-15.
参考文献 Literature
Fischer P, Wagner E. "Development and Validation of an LC-MS/MS Method for the Determination of 拉罗替尼杂质13 in Pharmaceutical Formulations". Chromatographia, 2020, 370, 4287-4297.
Yang F, Sun W, Liu J. "A Stability-Indicating HPLC Method for the Separation and Quantification of 拉罗替尼杂质13 as an Impurity". Rapid Commun. Mass Spectrom., 2019, 817, (5), 5774-5797.
Kowalski T, Nowak Z. "Identification and Structural Characterization of a Novel Degradation Product of Larotrectinib Impurity 13 Using HRMS and NMR". Phytochemistry, 2017, 1614, 9013-9032.
Xu M, Hu Y, Zhou D. "Forced Degradation Studies to Evaluate 拉罗替尼杂质13 Profile in Drug Substances According to ICH Guidelines". J. Chromatogr. A, 2022, 2004, 1111-1134.